Register now, it’s free to
- Receive our enewsletter, read a recent issue
- Enter competitions
- Join our meeting place
Most Popular Articles
Latest Comments1.
| Stepping up censorship |
2.
| Nothing new for pensioners |
3.
| A rose by any other name |
1.
| Dont throw away too soon and save |
2.
| Need to Feel More Secure at Home and When |
3.
| Enter to Win a Doro PhoneEasy 615 Mobile Phone |
Featured offers
Health > Wellbeing > Medication > New PBS medications
New PBS medications
8th Jun 2010
While not contagious or life threatening, psoriasis can have a devastating effect on people’s lives. New PBS measures may bring long-term relief.
Adalimumab will be available for treatment of severe psoriasis. This is an alternative to already listed medications, etanercept and infliximab. Etanercept, which is currently available for a course of 12 weeks and then a treatment-free period of 12 weeks, can now be prescribed to certain patients for a 24 week period with no treatment-free period necessary.
Efalizumab has been delisted.
Peptic ulcers can be extremely painful and difficult to treat for those unable to swallow tablets or who are being tube fed. A new granule formulation of pantoprazole is now available on the PBS. It is available as a restricted benefit listing for the treatment of gastro oesophageal reflux, scleroderma of the oesohagus and Zollinger-Ellison syndrome.
For more information on what medications are available, visit the PBS.
Adalimumab will be available for treatment of severe psoriasis. This is an alternative to already listed medications, etanercept and infliximab. Etanercept, which is currently available for a course of 12 weeks and then a treatment-free period of 12 weeks, can now be prescribed to certain patients for a 24 week period with no treatment-free period necessary.
Efalizumab has been delisted.
Peptic ulcers can be extremely painful and difficult to treat for those unable to swallow tablets or who are being tube fed. A new granule formulation of pantoprazole is now available on the PBS. It is available as a restricted benefit listing for the treatment of gastro oesophageal reflux, scleroderma of the oesohagus and Zollinger-Ellison syndrome.
For more information on what medications are available, visit the PBS.
